The Effect Of Macitentan On Long-Term Outcomes In Patients With Pulmonary Arterial Hypertension By Who Functional Class: Data From The Randomized Controlled Seraphin Study

被引：0

作者：

Channick, R. N. ^{[1
]}

Delcroix, M. ^{[2
]}

Galie, N. ^{[3
]}

Ghofrani, H. A. ^{[4
,5
]}

Jansa, P. ^{[6
]}

Le Brun, F. O. ^{[7
]}

Mehta, S. ^{[8
]}

Perchenet, L. ^{[7
]}

Pulido, T. ^{[9
]}

Sastry, B. ^{[10
]}

Sitbon, O. ^{[11
]}

Souza, R. ^{[12
]}

Torbicki, A. ^{[13
]}

Rubin, L. J. ^{[14
]}

Simonneau, G. ^{[11
]}

机构：

[1] Massachsetts Gen Hosp, Boston, MA USA

[2] Univ Hosp Gasthuisberg, Leuven, Belgium

[3] Univ Bologna, Bologna, Italy

[4] Univers Hosp Giessen & Marburg, German Ctr Lung Res, Giessen, Germany

[5] Imperial Coll London, Giessen, Germany

[6] Charles Univ Prague, Prague, Czech Republic

[7] Actel Pharmaceut Ltd, Allschwil, Switzerland

[8] Western Univ, London Hlth Sci Ctr, Victoria Hosp, London, ON, Canada

[9] Natl Inst Cardiol, Mexico City, DF, Mexico

[10] CARE Hosp, Hyderabad, Andhra Pradesh, India

[11] Univ Paris Sud, Hop Bicetre, Le Kremlin Bicetre, France

[12] Univ Sao Paulo, Inst Heart, Sao Paulo, Brazil

[13] ECZ Otwock, Ctr Postgrad Med Educ, Otwock, Poland

[14] Univ Calif San Diego, La Jolla, CA 92093 USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A4783

引用

页数：2

共 50 条

[1] Association Between WHO Functional Class and Long-term Prognosis in Patients With Pulmonary Arterial Hypertension: Data From SERAPHIN, A Randomized Controlled Study of Macitentan
Souza, Rogerio
Channick, Richard
Delcroix, Marion
Galie, Nazzareno
Ghofrani, Hossein
Jansa, Pavel
Le Brun, Franck-Olivier
Mehta, Sanjay
Perchenet, Loic
Pulido, Tomas
Sastry, B.
Sitbon, Olivier
Torbicki, Adam
Rubin, Lewis
Simonneau, Gerald
[J]. CHEST, 2013, 144 (04)
[2] Do Parameters of Cardiac Function Predict Long-term Outcomes in Patients With Pulmonary Arterial Hypertension? Data From SERAPHIN, a Randomized Controlled Study of Macitentan
Channick, Richard
Delcroix, Marion
Galie, Nazzareno
Ghofrani, Hossein A.
Jansa, Pavel
Le Brun, Franck-Olivier
Mehta, Sanjay
Perchenet, Loic
Pulido, Tomas
Sastry, B. K.
Sitbon, Olivier
Souza, Rogerio
Torbicki, Adam
Rubin, Lewis J.
Simonneau, Gerald
[J]. CHEST, 2013, 144 (04)
[3] EFFECT OF MACITENTAN ON HAEMODYNAMICS IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM THE LONG-TERM, RANDOMISED, PLACEBO-CONTROLLED SERAPHIN TRIAL
Coghlan, G.
Torbicki, A.
Galie, N.
Rubin, L. J.
Perchenet, L.
Simonneau, G.
[J]. THORAX, 2013, 68 : A26 - A26
[4] Effect of macitentan on haemodynamics in patients with pulmonary arterial hypertension: results from the long-term, randomised, placebo-controlled SERAPHIN trial
Torbicki, A.
Mehta, S.
Perchenet, L.
Pulido, T.
Sastry, B. K. S.
Sitbon, O.
Souza, R.
Rubin, L. J.
Simonneau, G.
[J]. EUROPEAN HEART JOURNAL, 2013, 34 : 186 - 186
[5] Anticoagulant therapy does not influence long-term outcomes in patients with pulmonary arterial hypertension (PAH): insights from the randomised controlled SERAPHIN trial of macitentan
Galie, N.
Delcroix, M.
Ghofrani, H. -A.
Jansa, P.
Minai, O. A.
Perchenet, L.
Rubin, L. J.
Sastry, B. K. S.
Torbicki, A.
Simonneau, G.
[J]. EUROPEAN HEART JOURNAL, 2014, 35 : 10 - 10
[6] Macitentan Reduced All-Cause Hospitalizations In Patients With Pulmonary Arterial Hypertension: Data From The Randomized Controlled Seraphin Trial
Mehta, S.
Delcroix, M.
Galie, N.
Ghofrani, H. A.
Jansa, P.
Le Brun, F. O.
Perchenet, L.
Pulido, T.
Rubin, L. J.
Sastry, B.
Simonneau, G.
Sitbon, O.
Souza, R.
Torbicki, A.
Channick, R. N.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
[7] Long-Term Survival And Safety With Macitentan In Patients With Pulmonary Arterial Hypertension: Results From The Seraphin Study And Its Open-Label Extension
Souza, R.
Pulido, T.
Channick, R. N.
Delcroix, M.
Galie, N.
Ghofrani, H.
Jansa, P.
Mehta, S.
Mitchell, L.
Papadakis, K.
Richard, D.
Rubin, L. J.
Sastry, B.
Sitbon, O.
Torbicki, A.
Simonneau, G.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
[8] Effect of macitentan on morbidity and mortality in pulmonary arterial hypertension: A randomised controlled trial (SERAPHIN)
Ghofrani, Hossein-Ardeschir
Channick, Richard
Delcroix, Marion
Galie, Nazzareno
Jansa, Pavel
Le Brun, Franck-Olivier
Mehta, Sanjay
Mittelholzer, Camilla
Pulido, Tomas
Sastry, B. K. S.
Sitbon, Olivier
Souza, Rogerio
Torbicki, Adam
Rubin, Lewis
Simonneau, Gerald
[J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
[9] Effect of macitentan on haemodynamics in SERAPHIN, a randomised controlled trial in pulmonary arterial hypertension (PAH)
Sitbon, Olivier
Channick, Richard
Delcroix, Marion
Galie, Nazzareno
Ghofrani, Hossein-Ardeschir
Jansa, Pavel
Le Brun, Franck-Olivier
Mehta, Sanjay
Perchenet, Loic
Pulido, Tomas
Sastry, B. K. S.
Souza, Rogerio
Torbicki, Adam
Rubin, Lewis
Simonneau, Gerald
[J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
[10] Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial
Souza, Rogerio
Channick, Richard N.
Delcroix, Marion
Galie, Nazzareno
Ghofrani, Hossein-Ardeschir
Jansa, Pavel
Le Brun, Franck-Olivier
Mehta, Sanjay
Perchenet, Loic
Pulido, Tomas
Sastry, B. K. S.
Sitbon, Olivier
Torbicki, Adam
Rubin, Lewis J.
Simonneau, Gerald
[J]. PLOS ONE, 2018, 13 (03):

← 1 2 3 4 5 →